Amgen recently presented 19 scientific abstracts at the 59th Annual Scientific Meeting of the American Headache Society, which took place in Boston. Read More »

OncoSec Medical Inc.'s pIL-12 drug, also known as tavokinogene telsaplasmid, has been given an Orphan Drug Designation by the U.S. Food and Drug Administration. Read More »

Amgen and Allergan's data supporting their Biologics License Application for ABP 215, a biosimilar candidate to Avastin (bevacizumab), will be reviewed by the Oncologic Drugs Advisory Committee of the U.S. Food and Drug Administration by July 13. Read More »

AbbVie recently announced positive top-line results from its Phase 3 Select-Next trial, which evaluated upadacitinib as a treatment for rheumatoid arthritis patients. Read More »

Navidea Biopharmaceuticals Inc. recently announced that SpePharm AG has launched Lymphoseek in the Denmark, the Netherlands and the United Kingdom. Read More »

Cigna and CVS Health have launched Cigna HealthWorks, a partnership that brings Cigna benefits to CVS Pharmacy and CVS MinuteClinic retail health care centers. Read More »

Ardsley, New York-based biopharmaceutical firm Acorda Therapeutics revealed new information derived from clinical and preclinical studies of tozadenant at the recent 2017 International Congress of Parkinson’s Disease and Movement Disorders (MDS) in Vancouver, British Columbia. Read More »

Purdue Pharma's Colace product line and Senokot tablets will now come with new packaging. Read More »

Do television ads by plaintiffs' lawyer firms hawking lawsuits over prescription drugs cause patients to cease taking their prescribed prescriptions? Read More »

Commencing a Phase 3b trial of daily oral medication ALKS 5461, Alkermes PLC will assess the treatment’s feasibility and safety for major depressive disorder patients with insufficient prior results obtained from other drugs. Read More »

The Health Affairs Blog, a vehicle for commentary on health policy and issues affecting the health care industry, recently release an article on surprise medical bills. Read More »

MD Logistics, a third-party logistics company that works with pharmaceutical companies, will expand its Indiana operations, creating 50 new jobs in the process. Read More »

Merck has paused enrollment in two Keytruda clinical trials. Read More »

A new study published in the Journal of the American Medical Association finds that doctors are influenced by gifts and their relationships with drug company representatives. Read More »

Drug Channels, a website providing expert insights on pharmaceutical economics and the drug distribution system, recently commented on a new report from the Centers for Medicare & Medicaid Services, titled “Medicare Part D – Direct and Indirect Remuneration.” Read More »

Sandoz has introduced the authorized generic version of Alcon Research Ltd.'s Pataday, an olopatadine hydrochloride ophthalmic solution. Read More »

Omnicell Inc. announced an agreement with CompleteRX to develop a medication distribution model for the Commonwealth of Massachusetts State Office of Pharmacy Services. Read More »

Global generic pharmaceutical giant Teva recently released its generic version of Zetia (ezetimibe) in 10mg tablets to address total and low-density lipoprotein (LDL) blood cholesterol levels for U.S. patients, company officials announced from Jerusalem headquarters. Read More »

After documenting recent product abuse, the U.S. Food and Drug Administration asked Endo Pharmaceuticals to voluntarily remove its reformulated Opana ER (oxymorphone hydrochloride) opioid medication from circulation, stating that risks may now outnumber benefits. Read More »

Alkermes PLC’s Aristada (aripiprazole lauroxil) injectable medication has won approval from the U.S. Food and Drug Administration as an extended-release injectable suspension to treat schizophrenia. Read More »